Peak K2 By AOR Advanced Orthomolecular Research Overview & Drug Interactions
Check For Interactions With Peak K2
Supplement: Peak K2 by AOR Advanced Orthomolecular Research
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Menatetrenone
Ingredient Group | Vitamin K (menaquinone) |
---|---|
Category | vitamin |
- Vitamin K2
Drugs that interact with Peak K2 by AOR Advanced Orthomolecular Research
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
1 Capsule(s)
|
Maximum serving Sizes: |
3 Capsule(s)
|
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Menatetrenone |
15 mg
|
Vitamin K (menaquinone) |
18750%
|
Other Ingredients: |
Microcrystalline Cellulose
Capsule
Forms
|
---|
Label Statments:
Precautions |
- Cautions: Clinical trials have documented that menatetrenone does not induce hemostatic activation. However, it will interfere with the activity warfarin (Coumadin) and possibly other anticoagulant (“blood thinning”) medications. Patients prescribed anticoagulants must not take this supplement.
- The information and product descriptions appearing on the website are for information purposes only, and are not intended to provide medical advice to individual. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes. Any reproduction in whole or part and in print or electronic form without express permission is strictly forbidden. Permission to reproduce selected material may be granted by contacting AOR Inc.
- Clinical trials have proven that high-dose vitamin K2 does not cause excessive or abnormal blood clotting, although it will interfere with “blood thinning” medications.
- Pregnancy/Nursing
Do not use.
|
---|---|
General Statements |
- AOR Peak K2 is menatetrenone (MK-4), a form of vitamin K2 made in the body from phylloquinone (vitamin K1) and distinct from the menaquinones made by probiotic bacteria. Available science indicates that vitamin K2 – and especially menatetrenone – is superior to Vitamin K1 in maintaining the health of the bones and vascular system. Clinical trials have proven that high-dose vitamin K2 does not cause excessive or abnormal blood clotting, although it will interfere with “blood thinning” medications.
- Advanced series
- Cardiovascular and skeletal support
- Product code
AOR08007
- Source
Solanesol (from Nicotiana tabacum).
|
Storage |
- Store in a cool dark place. Harmless clumping may occur at temperatures exceeding 35(0)
|
FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Brand IP Statement(s) |
- 2011, Advanced Orthomolecular Research
- Main applications
as reported by literature:
-Bone Health
-Brain Health
-Cardiovascular Function
|
Seals/Symbols |
- AOR
-Innovative research
-Scientific integrity
|
Formula |
- Menatetrenone
|
FDA Statement of Identity |
- Dietary Supplement
|
Formulation |
- 100% Vegetarian
- AOR guarantees that no ingredients not listed on the label have been added to the product.
Contains no corn, wheat, gluten, nuts, dairy, soy, eggs, fish, shellfish or any animal byproducts.
|
Suggested/Recommended/Usage/Directions |
- Adult Dosage: Take one to three capsules daily with food, or as directed by a qualified health care practitioner.
|
Brand Information
See all products by this brand
Not Present | |
---|---|
Name | Advanced Orthomolecular Research (AOR) |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.